Table 1.
Mouse mass and echocardiography data
Groups | ||||
Air | E-cig | 3R4F | P Value (ANOVA) | |
n | 8 | 9 | 12 | |
Body mass, g | ||||
Pre | 19.6 ± 0.2 | 19.4 ± 0.3 | 19.8 ± 0.3 | 0.59 |
Post | 28.9 ± 0.7 | 29.8 ± 1.0‡ | 27.1 ± 0.7 | 0.08 |
Δ | 9.3 ± 0.5 | 10.2 ± 0.9† | 7.4 ± 0.6¶ | 0.02 |
Heart mass, mg | 115.1 ± 3.2 | 118.5 ± 2.4 | 109.4 ± 2.5 | 0.09 |
Heart-to-body mass ratio | 4.0 ± 0.1 | 4.2 ± 0.2 | 4.2 ± 0.1 | 0.65 |
LV mass,a mg | 109 ± 10 | 126 ± 5†¶ | 102 ± 3 | 0.02 |
LV corrected,a mg | 87 ± 8 | 101 ± 4†¶ | 83 ± 2 | 0.03 |
Lung, mg | 84.8 ± 4.1 | 97.3 ± 8.7 | 91.2 ± 5.6 | 0.36 |
Spleen, mg | 84.5 ± 3.7 | 89.3 ± 3.9† | 72.6 ± 2.7* | <0.01 |
Echocardiography | ||||
n | 11 | 12 | 13 | |
Heart rate, beats/min | 461 ± 16 | 472 ± 18 | 477 ± 17 | 0.84 |
Stroke volume, µl | 31.0 ± 3.0 | 26.9 ± 2.4 | 25.4 ± 2.3 | 0.33 |
Cardiac output, ml/min | 12.5 ± 1.1 | 12.0 ± 1.4 | 12.8 ± 1.5 | 0.91 |
Stroke volume-to-body mass ratio, µl/g | 1.10 ± 0.14 | 0.87 ± 0.08 | 0.94 ± 0.09 | 0.34 |
Cardiac output-to-body mass ratio, ml/min/g | 0.44 ± 0.03 | 0.41 ± 0.05 | 0.47 ± 0.06 | 0.70 |
FS, % | 24.9 ± 3.2 | 21.4 ± 2.5‡ | 15.2 ± 2.0* | 0.04 |
EF, % | 72 ± 3 | 63 ± 3¶ | 56 ± 4* | 0.01 |
Area, mm2 | ||||
Systole | 8.40 ± 0.79 | 10.00 ± 1.03 | 11.67 ± 0.93 | 0.07 |
Diastole | 18.61 ± 0.91 | 18.30 ± 1.14 | 19.13 ± 0.81 | 0.83 |
Volume, µl | ||||
Systole | 13.5 ± 1.3 | 19.5 ± 2.1 | 20.4 ± 2.6 | 0.07 |
Diastole | 44.0 ± 3.5 | 43.9 ± 4.3 | 45.9 ± 2.8 | 0.91 |
Values are means ± SE. E-cig, electronic cigarette; EF, ejection fraction; FS, fractional shortening; LV, left ventricle; 3R4F, reference cigarette. Boldface indicates statistical significance.
Values are from echocardiographic analysis.
P < 0.05 vs. air,
P < 0.05 vs. 3R4F,
P < 0.10 vs. air, and
P < 0.10 vs. 3R4F.